Image

Para-aortic Lymph Node Metastasis in Resectable Pancreatic Cancer

Investigating Para-aortic Lymph Node Spread in Pancreatic Cancer

Recruiting
18 years and older
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates para-aortic lymph node (PALN) metastasis in pancreatic cancer. The purpose of this study is to understand the incidence and effects of PALN metastasis in patients undergoing surgery for cancer in the head of the pancreas.

The study evaluates how PALN metastasis impacts patient prognosis. It focuses on understanding if the removal of these lymph nodes can provide valuable information regarding the cancer's progression.

  • Who can participate: Adults over 18 years with resectable or borderline resectable periampullary cancer requiring surgery can participate. Written consent is necessary, and individuals must not have unresectable tumors or health conditions preventing surgery.
  • Study details: Participants will undergo surgery to remove para-aortic lymph nodes, which will be analyzed to study cancer spread. A placebo is not used in this study.
Print
Study details
    Pancreas Cancer
    Pancreas Adenocarcinoma
    Lymph Node Metastasis

NCT06065891

Jon Unosson

8 April 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.